The synthetic biology revolution is here! In this presentation, sponsored by Twist Bioscience, we are excited to bring together leaders in the field. Our April episode of GEN Live, our guests discuss where the field is now and the exciting advances in store for the future.
In this GEN webinar, sponsored by Horizon Discovery, we will present data showing how a new CRISPRsc screening platform from Horizon offers a streamlined approach to elucidating valuable and intriguing biological information critical to resolving complex biological questions.
In this GEN webinar, sponsored by 10X Genomics, Dr. Florian Wimmers from Stanford University takes us to the beginning of the COVID-19 pandemic, recounting how he and his colleagues leveraged and integrated a range of techniques, including Multiomic Cytometry (also known as CITE-seq), CyTOF, Olink, and blood transcriptional profiling, to uncover fundamental immune signatures of severe and moderate COVID-19.
In this GEN webinar, sponsored by OXGENE, our panelists—two industry leaders—will discuss what it takes to develop a cell or gene therapy from concept to commercialization, alongside a conversation about innovations that are likely to shape the future of advanced therapy discovery and biomanufacturing.
In this webinar , sponsored by TriLink, Dr. David Liu describes the development of two approaches to precision genome editing—base editing and prime editing—that do not require double-strand DNA breaks (DSBs).
In this GEN webinar, our guest presenter Daisy Hoagland from Icahn School of Medicine, will tell us how she and her colleagues used a broad range of small animal models to understand the host response to SARS-CoV-2. Moreover, the presentation will focus on the strengths of the golden hamster model in studying transmission, intrahost viral dissemination, pathology, and its utility in screening for effective antivirals.
On Demand Webinars
In this roundtable hear from four distinguished experts as they critically weigh the benefits of working with a manufacturing partner. This roundtable, sponsored by Catalent, is a must-see for early and late-stage cell therapy innovator companies who are considering a manufacturing partnership.
A large proportion of initially promising biotherapeutic candidates never make it to commercialization. It is critical to evaluate potential liabilities as early as possible during molecule design and utilize lead selection phases to increase the chances of identifying a successful candidate significantly. It is also essential that the best approaches and tools are selected to maximize success when moving the selected candidate through development. In this GEN webinar, we will introduce strategies and tools to increase the chance of success through both of these stages.
In the March episode of GEN Live, we are thrilled to welcome Walter Isaacson, who gives one of his first in-depth interviews on his new book The Code Breaker, published this month. We’ll talk to Walter about his impressions of Doudna and other key members of the CRISPR community, the impact of COVID-19, the role of innovation in science, and other adventures in gene editing and storytelling.
In this GEN Webinar, sponsored by Snthesis, we will hear about the challenges facing research teams as they work to curate large omics data sets in preparation for analysis. We will then explore modern strategies and technical approaches that can dramatically simplify and improve the process.
In this GEN webinar, sponsored by Horizon, we will hear about the gene-editing tools and options available at Horizon Discovery to customize the CHO expression host for both research and commercial use to suit specific needs during discovery, development, and protein production.